CN Stock MarketDetailed Quotes

688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist
  • 69.34
  • -0.06-0.09%
Market Closed Jul 12 15:00 CST
15.13BMarket Cap72.68P/E (TTM)

Jiangsu Sinopep-Allsino Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
71.02%355.82M
58.69%1.03B
85.61%709.47M
49.38%400.78M
54.98%208.06M
1.15%651.29M
-15.03%382.24M
-13.17%268.3M
-19.22%134.25M
13.58%643.87M
Operating revenue
71.02%355.82M
58.69%1.03B
85.61%709.47M
49.38%400.78M
54.98%208.06M
1.15%651.29M
-15.03%382.24M
-13.17%268.3M
-19.22%134.25M
13.58%643.87M
Total operating cost
50.01%268.73M
51.01%827.28M
57.57%576.24M
33.32%338.33M
49.65%179.15M
6.75%547.84M
0.78%365.71M
2.47%253.78M
-0.50%119.71M
15.13%513.2M
Operating cost
27.05%116.48M
45.99%403.4M
57.82%278.91M
33.89%169.99M
49.19%91.68M
-3.00%276.32M
-9.85%176.73M
-6.06%126.96M
-9.22%61.45M
20.12%284.87M
Operating tax surcharges
-3.39%705.18K
-22.15%7.2M
-7.15%4.78M
-29.31%3.23M
30.55%729.96K
76.45%9.25M
99.83%5.14M
123.96%4.57M
35.60%559.16K
43.75%5.24M
Operating expense
-37.07%11.49M
64.80%57.63M
70.84%45.8M
73.77%31.87M
53.71%18.25M
177.80%34.97M
176.22%26.81M
156.23%18.34M
337.91%11.87M
8.99%12.59M
Administration expense
59.03%70.57M
40.88%222.58M
35.66%153.61M
20.73%89.59M
29.45%44.38M
9.07%157.99M
8.39%113.23M
12.02%74.21M
5.85%34.28M
27.86%144.85M
Financial expense
-20.22%3.25M
7,188.15%11.59M
234.83%7.75M
200.49%3.78M
489.36%4.07M
-106.39%-163.5K
-201.10%-5.75M
-163.63%-3.76M
-138.11%-1.04M
-86.93%2.56M
-Interest expense (Financial expense)
87.40%6.35M
73.65%16.09M
81.94%11.06M
118.06%7.04M
218.94%3.39M
51.40%9.26M
14.61%6.08M
-30.37%3.23M
-42.81%1.06M
-47.40%6.12M
-Interest Income (Financial expense)
33.77%-1.26M
27.62%-6.21M
21.75%-5.13M
13.10%-3.85M
22.14%-1.91M
-62.00%-8.58M
-287.85%-6.55M
-481.30%-4.43M
-739.02%-2.45M
-618.54%-5.29M
Research and development
230.56%66.25M
79.77%124.89M
72.36%85.4M
19.11%39.86M
59.20%20.04M
10.12%69.47M
11.54%49.55M
7.42%33.46M
-12.35%12.59M
4.22%63.09M
Credit Impairment Loss
-206.30%-3.56M
12.48%-5.24M
-93.01%-5.51M
79.64%-527.58K
471.02%3.35M
-299.73%-5.99M
-952.39%-2.86M
-257.26%-2.59M
1,549.58%586.5K
18.79%-1.5M
Asset Impairment Loss
-4.11%-6.14M
-12.68%-28.89M
1.80%-16.69M
-7.30%-12.62M
-34.19%-5.9M
-62.74%-25.64M
-41.34%-16.99M
-42.69%-11.76M
-366.02%-4.4M
-108.36%-15.76M
Other net revenue
Fair value change income
----
113.11%257.52K
-76.95%-3.39M
-294.12%-2.77M
-308.00%-359.5K
-1,585.31%-1.96M
---1.92M
---703.72K
--172.83K
--132.28K
Invest income
-40.10%173.46K
-85.46%2.9M
-89.15%2.15M
-95.20%931.45K
-43.50%289.61K
547.10%19.96M
1,006.69%19.81M
5,224.31%19.41M
72.35%512.57K
-52.00%3.09M
Asset deal income
----
-99.07%176.42K
-99.50%95.2K
376.01%95.2K
--44.05K
31,919.42%18.89M
--18.89M
--20K
----
101.54%58.99K
Other revenue
17.62%3.27M
-12.05%14.19M
10.66%11.19M
-11.52%6.61M
-28.15%2.78M
38.87%16.14M
23.93%10.12M
42.37%7.47M
142.49%3.87M
-60.61%11.62M
Operating profit
177.61%80.82M
51.91%189.67M
177.80%121.07M
105.49%54.16M
90.53%29.11M
-2.70%124.85M
-48.89%43.58M
-56.33%26.36M
-67.35%15.28M
-10.78%128.31M
Add:Non operating Income
-58.44%69.73K
-54.11%554.64K
-57.03%442.09K
-46.03%233.69K
-1.82%167.81K
97.71%1.21M
227.73%1.03M
369.46%432.98K
3.19%170.91K
-82.35%611.36K
Less:Non operating expense
-92.37%439.18K
489.03%17.09M
199.31%6.67M
257.19%6.52M
1,005.68%5.75M
-9.12%2.9M
162.49%2.23M
352.51%1.83M
398.20%520.3K
344.89%3.19M
Total profit
241.94%80.45M
40.57%173.13M
170.97%114.85M
91.77%47.88M
57.59%23.53M
-2.05%123.16M
-49.98%42.38M
-58.43%24.97M
-68.13%14.93M
-14.21%125.73M
Less:Income tax cost
242.17%15.89M
1,879.38%7.67M
490.92%24.51M
214.35%8.02M
7,467.61%4.64M
-97.71%387.71K
-141.22%-6.27M
-165.51%-7.02M
-100.74%-63.01K
-36.22%16.92M
Net profit
241.88%64.56M
34.77%165.45M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
-9.35%108.81M
Net profit from continuing operation
241.88%64.56M
34.77%165.45M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
-9.35%108.81M
Less:Minority Profit
17.19%-1.76M
139.72%2.52M
69.76%-1.37M
29.80%-2M
-93.46%-2.13M
3.71%-6.34M
-20.88%-4.54M
-37.20%-2.85M
16.34%-1.1M
-92.76%-6.58M
Net profit of parent company owners
215.65%66.33M
26.20%162.94M
72.41%91.71M
20.15%41.85M
30.57%21.01M
11.89%129.11M
-27.41%53.19M
-32.25%34.83M
-59.45%16.09M
-6.52%115.39M
Earning per share
Basic earning per share
210.00%0.31
24.59%0.76
72.00%0.43
25.00%0.2
25.00%0.1
1.67%0.61
-37.50%0.25
-46.67%0.16
-68.00%0.08
-22.08%0.6
Diluted earning per share
200.00%0.3
24.59%0.76
72.00%0.43
25.00%0.2
25.00%0.1
1.67%0.61
-37.50%0.25
-46.67%0.16
-68.00%0.08
-22.08%0.6
Other composite income
-24.62M
Other composite income of parent company owners
----
---24.62M
----
----
----
----
----
----
----
----
Total composite income
241.88%64.56M
14.71%140.83M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
-9.35%108.81M
Total composite income of parent company owners
215.65%66.33M
7.14%138.32M
72.41%91.71M
20.15%41.85M
30.57%21.01M
11.89%129.11M
-27.41%53.19M
-32.25%34.83M
-59.45%16.09M
-6.52%115.39M
Total composite income of minority owners
17.19%-1.76M
139.72%2.52M
69.76%-1.37M
29.80%-2M
-93.46%-2.13M
3.71%-6.34M
-20.88%-4.54M
-37.20%-2.85M
16.34%-1.1M
-92.76%-6.58M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 71.02%355.82M58.69%1.03B85.61%709.47M49.38%400.78M54.98%208.06M1.15%651.29M-15.03%382.24M-13.17%268.3M-19.22%134.25M13.58%643.87M
Operating revenue 71.02%355.82M58.69%1.03B85.61%709.47M49.38%400.78M54.98%208.06M1.15%651.29M-15.03%382.24M-13.17%268.3M-19.22%134.25M13.58%643.87M
Total operating cost 50.01%268.73M51.01%827.28M57.57%576.24M33.32%338.33M49.65%179.15M6.75%547.84M0.78%365.71M2.47%253.78M-0.50%119.71M15.13%513.2M
Operating cost 27.05%116.48M45.99%403.4M57.82%278.91M33.89%169.99M49.19%91.68M-3.00%276.32M-9.85%176.73M-6.06%126.96M-9.22%61.45M20.12%284.87M
Operating tax surcharges -3.39%705.18K-22.15%7.2M-7.15%4.78M-29.31%3.23M30.55%729.96K76.45%9.25M99.83%5.14M123.96%4.57M35.60%559.16K43.75%5.24M
Operating expense -37.07%11.49M64.80%57.63M70.84%45.8M73.77%31.87M53.71%18.25M177.80%34.97M176.22%26.81M156.23%18.34M337.91%11.87M8.99%12.59M
Administration expense 59.03%70.57M40.88%222.58M35.66%153.61M20.73%89.59M29.45%44.38M9.07%157.99M8.39%113.23M12.02%74.21M5.85%34.28M27.86%144.85M
Financial expense -20.22%3.25M7,188.15%11.59M234.83%7.75M200.49%3.78M489.36%4.07M-106.39%-163.5K-201.10%-5.75M-163.63%-3.76M-138.11%-1.04M-86.93%2.56M
-Interest expense (Financial expense) 87.40%6.35M73.65%16.09M81.94%11.06M118.06%7.04M218.94%3.39M51.40%9.26M14.61%6.08M-30.37%3.23M-42.81%1.06M-47.40%6.12M
-Interest Income (Financial expense) 33.77%-1.26M27.62%-6.21M21.75%-5.13M13.10%-3.85M22.14%-1.91M-62.00%-8.58M-287.85%-6.55M-481.30%-4.43M-739.02%-2.45M-618.54%-5.29M
Research and development 230.56%66.25M79.77%124.89M72.36%85.4M19.11%39.86M59.20%20.04M10.12%69.47M11.54%49.55M7.42%33.46M-12.35%12.59M4.22%63.09M
Credit Impairment Loss -206.30%-3.56M12.48%-5.24M-93.01%-5.51M79.64%-527.58K471.02%3.35M-299.73%-5.99M-952.39%-2.86M-257.26%-2.59M1,549.58%586.5K18.79%-1.5M
Asset Impairment Loss -4.11%-6.14M-12.68%-28.89M1.80%-16.69M-7.30%-12.62M-34.19%-5.9M-62.74%-25.64M-41.34%-16.99M-42.69%-11.76M-366.02%-4.4M-108.36%-15.76M
Other net revenue
Fair value change income ----113.11%257.52K-76.95%-3.39M-294.12%-2.77M-308.00%-359.5K-1,585.31%-1.96M---1.92M---703.72K--172.83K--132.28K
Invest income -40.10%173.46K-85.46%2.9M-89.15%2.15M-95.20%931.45K-43.50%289.61K547.10%19.96M1,006.69%19.81M5,224.31%19.41M72.35%512.57K-52.00%3.09M
Asset deal income -----99.07%176.42K-99.50%95.2K376.01%95.2K--44.05K31,919.42%18.89M--18.89M--20K----101.54%58.99K
Other revenue 17.62%3.27M-12.05%14.19M10.66%11.19M-11.52%6.61M-28.15%2.78M38.87%16.14M23.93%10.12M42.37%7.47M142.49%3.87M-60.61%11.62M
Operating profit 177.61%80.82M51.91%189.67M177.80%121.07M105.49%54.16M90.53%29.11M-2.70%124.85M-48.89%43.58M-56.33%26.36M-67.35%15.28M-10.78%128.31M
Add:Non operating Income -58.44%69.73K-54.11%554.64K-57.03%442.09K-46.03%233.69K-1.82%167.81K97.71%1.21M227.73%1.03M369.46%432.98K3.19%170.91K-82.35%611.36K
Less:Non operating expense -92.37%439.18K489.03%17.09M199.31%6.67M257.19%6.52M1,005.68%5.75M-9.12%2.9M162.49%2.23M352.51%1.83M398.20%520.3K344.89%3.19M
Total profit 241.94%80.45M40.57%173.13M170.97%114.85M91.77%47.88M57.59%23.53M-2.05%123.16M-49.98%42.38M-58.43%24.97M-68.13%14.93M-14.21%125.73M
Less:Income tax cost 242.17%15.89M1,879.38%7.67M490.92%24.51M214.35%8.02M7,467.61%4.64M-97.71%387.71K-141.22%-6.27M-165.51%-7.02M-100.74%-63.01K-36.22%16.92M
Net profit 241.88%64.56M34.77%165.45M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M-9.35%108.81M
Net profit from continuing operation 241.88%64.56M34.77%165.45M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M-9.35%108.81M
Less:Minority Profit 17.19%-1.76M139.72%2.52M69.76%-1.37M29.80%-2M-93.46%-2.13M3.71%-6.34M-20.88%-4.54M-37.20%-2.85M16.34%-1.1M-92.76%-6.58M
Net profit of parent company owners 215.65%66.33M26.20%162.94M72.41%91.71M20.15%41.85M30.57%21.01M11.89%129.11M-27.41%53.19M-32.25%34.83M-59.45%16.09M-6.52%115.39M
Earning per share
Basic earning per share 210.00%0.3124.59%0.7672.00%0.4325.00%0.225.00%0.11.67%0.61-37.50%0.25-46.67%0.16-68.00%0.08-22.08%0.6
Diluted earning per share 200.00%0.324.59%0.7672.00%0.4325.00%0.225.00%0.11.67%0.61-37.50%0.25-46.67%0.16-68.00%0.08-22.08%0.6
Other composite income -24.62M
Other composite income of parent company owners -------24.62M--------------------------------
Total composite income 241.88%64.56M14.71%140.83M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M-9.35%108.81M
Total composite income of parent company owners 215.65%66.33M7.14%138.32M72.41%91.71M20.15%41.85M30.57%21.01M11.89%129.11M-27.41%53.19M-32.25%34.83M-59.45%16.09M-6.52%115.39M
Total composite income of minority owners 17.19%-1.76M139.72%2.52M69.76%-1.37M29.80%-2M-93.46%-2.13M3.71%-6.34M-20.88%-4.54M-37.20%-2.85M16.34%-1.1M-92.76%-6.58M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg